Article
Isolation and characterization of a pufferfish MLL (mixed lineage leukemia)-like gene (fMll) reveals evolutionary conservation in vertebrate genes related to Drosophila trithorax.
The Leukaemia Research Fund Centre at The Institute of Cancer Research, Chester Beatty Laboratories, London, UK.
Oncogene (impact factor:
6.37).
07/1998;
16(25):3233-41.
DOI:10.1038/sj.onc.1201873
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Interaction of MLL amino terminal sequences with menin is required for transformation.
[show abstract] [hide abstract]
ABSTRACT: Rearrangements of the mixed lineage leukemia gene MLL are associated with aggressive lymphoid and myeloid leukemias. The resulting MLL fusion proteins enforce high-level expression of HOX genes and the HOX cofactor MEIS1, which is pivotal for leukemogenesis. Both wild-type MLL and MLL fusion proteins interact with the tumor suppressor menin and with the Hoxa9 locus in vivo. Here, we show that MLL sequences between amino acids 5 and 44 are required for interaction with menin and for the transformation of hematopoietic progenitors. Blocking the MLL-menin interaction by the expression of a dominant negative inhibitor composed of amino terminal MLL sequences down-regulates Meis1 expression and inhibits cell proliferation, suggesting that targeting this interaction may be an effective therapeutic strategy for leukemias with MLL rearrangements.Cancer Research 09/2007; 67(15):7275-83. · 7.86 Impact Factor -
Article: Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.
[show abstract] [hide abstract]
ABSTRACT: The MLL gene is a frequent target for leukemia-associated chromosomal translocations that generate dominant-acting chimeric oncoproteins. These invariably contain the amino-terminal 1,400 residues of MLL fused with one of a variety of over 30 distinct nuclear or cytoplasmic partner proteins. Despite the consistent inclusion of the MLL amino-terminal region in leukemia oncoproteins, little is known regarding its molecular contributions to MLL-dependent oncogenesis. Using high-resolution mutagenesis, we identified three MLL domains that are essential for in vitro myeloid transformation via mechanisms that do not compromise subnuclear localization. These include the CXXC/Basic domain and two novel domains of unknown function. Point mutations in the CXXC domain that eliminate myeloid transformation by an MLL fusion protein also abolished recognition and binding of nonmethylated CpG DNA sites in vitro and transactivation in vivo. Our results define a critical role for the CXXC DNA binding domain in MLL-associated oncogenesis, most likely via epigenetic recognition of CpG DNA sites within the regulatory elements of target genes.Molecular and Cellular Biology 01/2005; 24(23):10470-8. · 5.53 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
chromosomal translocations
compact model vertebrate genome
comparative analysis
DNA methyltransferase domain
Drosophila trx
Drosophila TRX proteins
functional role
functional study
genomic region encoding
human leukemogenesis
human MLL proteins
key structural
large regions
MLL gene
MLL leukemia-associated fusion proteins
MLL protein
MLL-like gene
partner genes
regions
unique domain structure